Monte Rosa Therapeutics reported a net margin of -483.91% for the quarter ended Jun 2026. These financial ratios cover 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||
| EBT Margin | -2,996.71% | -640.21% | -258.12% | 25.72% | 56.17% | -7.91% | -236.98% | -1,656.81% | -1,055.84% | -481.59% | |||||||||||
| EBIT Margin | -3,284.49% | -695.25% | -287.84% | 21.44% | 51.85% | -11.09% | -258.26% | -1,787.67% | -1,188.46% | -547.84% | |||||||||||
| EBITDA Margin | -3,284.49% | -695.25% | -287.84% | 21.44% | 51.85% | -11.09% | -258.26% | -1,787.67% | -1,188.46% | -547.84% | |||||||||||
| Operating Margin | -3,284.49% | -695.25% | -287.84% | 21.44% | 51.85% | -11.09% | -258.26% | -1,787.67% | -1,188.46% | -547.84% | |||||||||||
| Net Margin | -3,006.11% | -645.58% | -258.89% | 50.68% | 55.20% | -8.77% | -212.10% | -1,399.64% | -1,058.22% | -483.91% | |||||||||||
| FCF Margin | -3,717.01% | -634.48% | -232.13% | 212.28% | -55.43% | -25.97% | 781.46% | -1,574.29% | -952.61% | -534.89% | |||||||||||
| Efficiency | |||||||||||||||||||||
| Assets AverageAssets Avg. | 376.50M | 375.19M | 356.17M | 355.53M | 361.33M | 350.00M | 325.71M | 293.82M | 265.36M | 277.93M | 285.25M | 305.43M | 329.60M | 376.91M | 415.97M | 376.39M | 409.71M | 454.25M | 592.54M | 713.79M | |
| Asset Utilization RatioAsset Util. | 0.00 | 0.02 | 0.05 | 0.20 | 0.38 | 0.78 | 0.73 | 0.53 | 0.27 | 0.04 | |||||||||||
| Valuation | |||||||||||||||||||||
| Price to EarningsP/E | -52.16 | -21.84 | -27.07 | -17.06 | -14.47 | -12.19 | -12.00 | -9.66 | -6.87 | -8.52 | -11.06 | -7.57 | -18.22 | 13.89 | 8.13 | -30.15 | -22.55 | -33.46 | -31.13 | -47.53 | |
| Price to SalesP/S | 332.62 | 48.85 | 47.16 | 7.04 | 4.49 | 2.64 | 47.82 | 468.38 | 329.48 | 229.98 | |||||||||||
| Price to BookP/B | 2.80 | 1.47 | 2.01 | 1.49 | 1.36 | 1.38 | 1.58 | 1.59 | 1.30 | 1.58 | 2.32 | 1.02 | 2.12 | 1.91 | 1.39 | 1.38 | 2.48 | 5.59 | 2.66 | 4.23 | |
| Enterprise Value | 668.63M | 164.43M | 515.46M | 347.78M | 281.85M | 110.53M | 331.72M | 292.68M | 180.76M | 46.87M | 254.16M | 120.52M | 309.09M | 45.90M | 302.64M | 301.23M | 208.94M | 913.62M | 709.00M | 1,429.58M | |
| EV to EBIT | -33.65 | -7.03 | -21.21 | -12.77 | -9.94 | -3.40 | -9.68 | -7.86 | -4.89 | -1.34 | -7.27 | -3.69 | -11.65 | 3.53 | 6.87 | -19.37 | -6.34 | -18.38 | -14.17 | -29.10 | |
| EV to EBITDA | -33.65 | -7.03 | -21.21 | -12.77 | -9.94 | -3.40 | -9.68 | -7.86 | -4.89 | -1.34 | -7.27 | -3.69 | -11.65 | 3.53 | 6.87 | -19.37 | -6.34 | -18.38 | -14.17 | -29.10 | |
| Market Capitalization | 1,035.66M | 510.50M | 653.76M | 451.44M | 395.21M | 375.35M | 384.52M | 339.71M | 239.81M | 283.29M | 353.91M | 229.37M | 434.66M | 426.86M | 381.17M | 370.66M | 610.57M | 1,302.56M | 1,387.09M | 2,062.48M | |
| Price to FCFP/FCF | -52.98 | -29.63 | -22.47 | -19.58 | -17.96 | -12.02 | -11.80 | -10.67 | -9.10 | 10.14 | -8.95 | -7.70 | -20.32 | 3.32 | -8.10 | -10.18 | 6.12 | -29.75 | -34.59 | -43.00 | |
| EV to FCF | -34.20 | -9.54 | -17.72 | -15.09 | -12.81 | -3.54 | -10.18 | -9.19 | -6.86 | 1.68 | -6.43 | -4.05 | -14.45 | 0.36 | -6.43 | -8.27 | 2.09 | -20.87 | -17.68 | -29.80 | |
| EV to CFO | -37.58 | -11.60 | -18.81 | -16.96 | -13.68 | -4.61 | -14.17 | -11.56 | -7.32 | 1.58 | -6.66 | -4.34 | -14.72 | 0.36 | -6.65 | -8.68 | 2.08 | -21.24 | -18.97 | -32.41 | |
| Return Ratios | |||||||||||||||||||||
| Return on Sales [ROS]ROS | -3,284.49% | -695.25% | -287.84% | 21.44% | 51.85% | -11.09% | -258.26% | -1,787.67% | -1,188.46% | -547.84% | |||||||||||
| Return on Capital Employed [ROCE]ROCE | -16.89% | -20.33% | -24.93% | -27.82% | -30.42% | -34.64% | -40.09% | -48.17% | -58.06% | -61.95% | -59.03% | -52.99% | -44.79% | -36.88% | -0.60% | 4.47% | 2.44% | -13.90% | -28.43% | -27.80% | |
| Return on Assets [ROA]ROA | -16.31% | -19.41% | -24.00% | -26.40% | -28.04% | -31.06% | -35.80% | -42.65% | -50.08% | -48.70% | -47.43% | -42.70% | -36.23% | -14.70% | 5.64% | 11.02% | 9.33% | -6.92% | -20.73% | -21.57% |